Can angiogenesis inhibitor therapy cause changes in imaging features of hepatic hemangioma- Initial study

BACKGROUND: To observe whether anti-angiogenesis therapy can induce changes in size and enhancement characteristics of hepatic hemangioma. METHOD: 133 patients with hepatic hemangioma lesions were analyzed and classified into a Bevacizumab group (n=65) and the control group (n=68). The parameters (V...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Tang, Pan, Wenxue, Lai, Shengyuan, Luo, Jiawen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036792/
https://www.ncbi.nlm.nih.gov/pubmed/36969035
http://dx.doi.org/10.3389/fonc.2023.1134179

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10036792/
https://www.ncbi.nlm.nih.gov/pubmed/36969035
http://dx.doi.org/10.3389/fonc.2023.1134179

Ejemplares similares